Published ahead of print on August 6, 2003, doi:10.1165/rcmb.2002-0266OC
© 2004 American Thoracic Society DOI: 10.1165/rcmb.2002-0266OC Fetal Lungs of Tenascin-C–Deficient Mice Grow Well, but Branch Poorly in Organ CultureInstitute of Anatomy, University of Bern, Bern; Division of Neonatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; and Max-Planck-Institute of Biochemistry, Martinsried, Germany Address correspondence to: Johannes C. Schittny, Institute of Anatomy, University of Bern, Buehlstrasse 26, CH-3000 Bern 9, Switzerland. E-mail: schittny{at}ana.unibe.ch
Tenascin-C (TNC) is a multidomain extracellular matrix protein that contributes to organogenesis and tumorgenesis. To elucidate its developmental function in the context of TNC deficiency, lung lobes of TNC null mice were obtained at Embryonic Days E11.5 and E12.5 and cultured for 3 d. In lung explants of homozygote TNC-deficient embryos (E12.5) the number of future airway branches was reduced by 36% as compared with wild-type. In heterozygote explants only half of the reduction (18%) was observed. No significant alteration, neither of the explant growth nor of the pattern of airway branching, was noticed in TNC-null explants. However, the terminal endbuds of the transgenic explants were enlarged. The results are supported by a morphologic investigation at Postnatal Day P2, where the airspaces of TNC-deficient lungs appeared larger than in wild-type lungs. Taken together, our results represent the first developmental phenotype of TNC-null mice. We conclude that TNC takes part in the control of fetal lung branching, and that not only the presence of TNC but also its amount is important. Because TNC is predominantly expressed at the growing tip of the future airways, we hypothesize that TNC promotes the penetration into the surrounding mesenchyme and the branching of the growing airways.
Abbreviations: embryonic, E • postnatal, P • phosphate-buffered saline, PBS • Tenascin-C, TNC • transferase-mediated deoxyuridine triphosphate nick end labeling, TUNEL
Mouse lung development comprises six different stages. Organogenesis starts with the embryonic period (Embryonic Days E9.5–E12). The lung anlage forms by a ventral outpouching of the foregut at the caudal end of the laryngotracheal sulci. The two formed lung buds, will give rise to the main bronchi (1). Cranial of the lung buds, the prospective trachea, and esophagus form by separation from the foregut (2). The prospective main bronchi divide dichotomously and invade the surrounding mesenchyme forming the future bronchi. Looking like a primitive gland, the developing lung enters the pseudoglandular stage (E12–E16.5). Most of the branching morphogenesis takes place during this stage. Epithelial differentiation starts and the future bronchi and bronchioli begin to acquire their smooth muscle layer. The canalicular stage (E16.5–E17.5) is characterized by a "canalization" of the future lung parenchyma by capillaries. Branching comes to completion, the formation of the air–blood barrier starts, and the epithelial type II cells produce the first surfactant. During the saccular stage (E17.5–P4) terminal clusters of widened spaces (saccules) are formed in the peripheral airways. The capillary network surrounding the saccules condenses and forms two capillary layers located directly underneath both septal surfaces. As a result the septa now contain two sheets of capillary layers separated by a core of connective tissue. After birth, during the phase of alveolarization (P4–P14), the alveoli are formed by lifting off of secondary alveolar septa from the existing primary septa. The double capillary layer of the immature alveolar septa is reduced to a single capillary layer during the phase of microvascular maturation (P14–P21) (3, 4).
Tenascin-C (TNC) belongs to a family of at least five large extracellular matrix glycoproteins (tenascin-C, tenascin-R, tenascin-W, tenascin-X, and tenascin-Y). TNC is detectable only in small amounts in normal adult tissues. Larger amounts are expressed during development, as well as in adults during tissue repair and remodeling, especially during neovascularization, wound healing, and tumorgenesis (5, 6). Whereas tenascin-R is highly restricted to the central nervous system, the expression of TNC and tenascin-X is frequently reciprocal. In skin, tendons, ligaments, heart, uterus, placenta, aorta, skeletal muscle, and nerves, expression of tenascin-X prevails. But in fetal brain and spleen, adult spinal cord, kidney, and in lung, TNC appears to be leading (7, 8). Tenascin-W, the newest member of the tenascin family, was identified in zebra fish and colocalizes with TNC in neural crest (9). TN-Y represents the avian homolog to mammalian tenascin-X and has been identified in heart and skeletal muscle and in the connective tissue of skeletal muscle (10). The expression of TNC is upregulated by different factors like transforming growth factor ß1, fibroblast growth factor, keratinocyte growth factor, nerve growth factor, and mechanical stress. Glucocorticoids downregulate TNC expression. TNC contributes to the regulation of cell proliferation, migration, growth, and survival during organogenesis and tissue repair. Its developmental role is underlined by its accumulation in the vicinity of actively growing epithelia—meaning in their basement membranes and their surrounding mesenchyme (11–13).
Throughout prenatal lung development TNC accumulates in the basement membranes and mesenchyme surrounding the branching and growing tips of the bronchial tree. In chicken TNC is expressed by epithelial cells (14), whereas in mice and rats it is predominantly expressed by mesenchymal cells at the sites of branching (3, 15, 16). Perturbation of fetal lung organ cultures with functional anti-TNC antibodies or bacterially expressed TNC fragments resulted in a reduction of the number of branches. The growth of these explants was not altered (16, and J.C.S., unpublished results). Postnatally TNC is expressed at the tips of the newly forming septa during the phase of alveolarization. In 3D these tips represent the alveolar entrance rings (alveolar mouths). In addition, they contain elastic fibers, collagen, and smooth muscle cells. It is believed that they have to bear mechanical forces. In later stages no TNC expression was observed anymore (16).
According to the described developmental role of TNC, it was rather surprising when Saga and coworkers presented a homozygous TNC-deficient mouse without an apparent phenotype (17). Forsberg and colleagues repeated this experiment obtaining the same result by introducing an independently produced TNC-null mouse (18). Both mouse strains showed no significant difference from wild-type with respect to size, life span, or fertility. A brief histologic examination of the principal organ systems including lung did not reveal any further phenotype. More detailed investigations were necessary to recognize subtle phenotypes like abnormal behavior (19), reduced haemopoietic activity of bone marrow cells (20), decreased reaction on suture wounds of cornea (21), a reduced proliferation of mesangial cells, and abnormal restoration after habu-snake venom–induced glomerulonephritis (22) (for review see Ref. 11). Due to the complexity of lung development, a lung phenotype may easily be overseen or an early developmental phenotype may be rescued during later stages of development. Therefore, we investigated lung branching morphogenesis in TNC null mice of Forsberg and associates (18) using lung organ cultures.
Animals The TNC-null mouse strain of Forsberg and coworkers was used (18). Wild-type littermates and 129/Sv mice were used as controls. Fetuses (12.5 d old) were obtained from heterozygote breeding; 11.5-d-old fetuses were obtained from homozygote breeding. Phenotyping was done according to Forsberg and colleagues (18). Handling of the animals before and during the experiments, as well as the experiments themselves, were approved and supervised by the Swiss Agency for the Environment, Forests and Landscape and the Veterinary Service of the Canton of Bern.
Lung Organ Culture
Statistical Evaluations
The size of the terminal endbuds was measured as follows. For all explants obtained at Day E11.5 branching of the endbuds was followed individually in the time interval of 15–40 h after explantation. At time point 40 h the endbuds were grouped into the categories "no branching," "branched once," and "branched twice," and their size was measured on x23 enlarged prints using a graphics tablet of a pentium base personal computer system and the software SigmaScan (SPSS Inc., Chicago, IL). A histogram of the categories was drawn and the mean size of terminal endbuds was calculated separately for homozygote null, heterozygote, and wild-type explants.
For the estimation of the size of the airspaces at Day P2, central paraffin sections of three TNC-null and three wild-type left lungs were photographed in a meandering pattern covering
For all experiments significance was determined using the Student's t-test. P < 0.05 was defined as "significant" and P < 0.001 as "highly significant."
Transferase-Mediated dUTP Nick End Labeling Assay and Cell Proliferation
Morphology
Volumetry
Lung Organ Culture Lung organ cultures were used to compare branching morphogenesis of TNC null and wild-type lungs. Fetal lungs of TNC-deficient (18) and of wild-type embryos were explanted at Days E11.5 or E12.5 and cultured for at least 3 d (Table 1). As wild-type controls 129 SV mice were used at Day E11.5 and homozygote TNC expressing littermates at Day E12.5.
Branching Morphogenesis and Growth In our current study we characterized lung branching morphogenesis (1) by the number of branches occurring (called branching) and (2) by the pattern of airway branching (called branching pattern). The number of terminal endbuds was taken as a measure of branching. After 48 h in culture homozygote TNC-deficient explants showed a highly significant reduction of the number of endbuds as compared with wild-type (36%, P < 0,001, start of culture = E12.5). In lung explants of heterozygote TNC-deficient fetuses the number of the terminal endbuds was also reduced, but only half of the reduction mentioned above was observed (18%, P < 0.002; Figures 1 and 2, Table 1). Similar results were obtained using lungs which were explanted at Day E11.5 (Table 1). Comparing the growth of the explants, we did not detect any significant difference between TNC null and wild-type explants (Figures 1 and 2). However, we observed an enlargement of the size of the terminal endbuds in the TNC-null explants (Figures 1 and 3). The latter results were confirmed by morphometric measurements (Figure 4). Branching was followed for every individual terminal endbud between 15 and 40 h after explantation and their size was measured at the latter time point. In the group of "no branching" the size of the homozygote as well as of the heterozygote TNC-deficient endbuds was roughly twice as large as that in controls. The size of the homozygote TNC-null endbuds which had branched once was enlarged by > 20%. In contrast to wild-type and heterozygote TNC-deficient explants, the homozygote TNC-null explants did not contain any endbud that branched twice during the period of observation (Figure 4).
In vivo the branching pattern of the larger airways appears to be very constant (31). We also observed this in our wild-type lung organ cultures, when whole lungs were explanted at Day E11.5. As shown in Figure 3, TNC-null explants showed the same very constant branching pattern as the wild type up to the time point (  3 d in culture) where the bronchial tree became too complex to be compared.
Cell Proliferation and Cell Death
Lung Morphology at Postnatal Day 2 We studied the lung morphology at Postnatal Day 2 to support our in vitro data with in vivo observations. Day P2 was chosen because at this time point branching morphogenesis is completed and alveolarization has not yet started (3). Therefore, we were able to investigate the end point of branching morphogenesis. We did not study any earlier time point, because it would not have been possible to distinguish between reduced or delayed branching. The total and the specific lung volumes of TNC null and wild-type mice at Day P2 did not show any significant difference (Table 2). But comparing the morphology of the lung parenchyma of TNC-deficient and wild-type lungs, we observed an enlargement of the airspaces of the gas exchange area in TNC-null lungs (Figure 6). This result was verified by estimating the mean volume-weighted airspace volume. In TNC-deficient lungs the airspace volume was estimated to be almost two times (factor 1.85) larger than in wild-type lungs. Because we did not detect any other morphologic differences between knockout and wild type, the enlarged airspaces may be taken as an in vivo confirmation of the reduced branching observed in TNC-null lung organ cultures.
Despite the fact that many in vitro studies attributed a developmental role to TNC, no developmental phenotype was described in TNC-deficient mice until now (see above; 11, 13). Using lung organ cultures we were able to show that the number of branches was reduced by 36–46% in homozygote TNC-deficient lung explants as compared with wild-type controls (Figures 1–3, Table 1). In heterozygote TNC-deficient lung explants half of the reduction was observed (Figures 1 and 2, Table 1), predicting that not only the presence of TNC, but also its amount is important. These results represent the first mammalian TNC null phenotype, where a developmental process caused structural alterations. However, it may be argued that lung organ cultures are only in vitro studies. Therefore, we investigated the lung at Postnatal Day P2. At this time point branching morphogenesis is completed and septation (alveolarization) has not yet started (3). Volumetric comparison of TNC-null and wild-type lungs did not reveal any significant difference for either total or specific lung volume (Table 2). Based on morphologic observations and on the estimation of the mean volume-weighted airspace volume, the airspaces of the lung parenchyma appeared to be almost two times larger in TNC-null lungs than in the wild-type ones (see RESULTS and Figure 6). Because we did not observe any alteration of the nonparenchymal structures in TNC-deficient lungs, we conclude that the enlarged airspaces of the TNC-null lungs represent the result of a reduced branching of the bronchial tree in the knockout mice. These morphologic in vivo observations are supported by our in vitro data. We measured the size of the terminal endbuds and were able to show that especially those endbuds were enlarged that did not branch during the observation period of 25 h (Figure 4). This result represents further evidence that TNC deficiency leads to an inhibition of branching, but not to an inhibition of growth of the epithelial tubules (Figures 1, 2, and 4). Our results reflect previously reported perturbation experiments using anti-TNC antibodies and bacterially expressed TNC fragments in rat lung organ cultures. Young and coworkers (16) described reduced branching, enlarged terminal buds, and unaltered explant growth after perturbation. Therefore, the lung represents one of the very few examples where the results of perturbation experiments correctly predicted a phenotype of the TNC-null mouse. One reason for this result may be that the lung represents one of the few organs in which TNC is more abundant than tenascin-X (7). During branching morphogenesis TNC is expressed at the epithelial–mesenchymal interface and accumulates at the growing tips of the bronchial tree where airway subdivision takes place (15, 16, 32). This zone is characterized by an intensive and specific epithelial cell proliferation and migration (33). As a multifunctional protein, TNC is involved in processes like cell proliferation and migration (13). Because both cell proliferation and cell death were not significantly altered in the developing TNC-null lungs (Figure 5), we hypothesize that TNC predominately influences cell migration, or more specifically the penetration of the growing bronchial tip into the surrounding mesenchyme. In a growing organ, cleft formation (formation of the branching point) is viewed as a spot where the epithelial cells of the growing tip stop moving, while their neighbors continue their penetration into the mesenchyme. Therefore, we further hypothesize that TNC also takes part in the control of cleft formation. This view is supported by our observation that the terminal ends of the bronchial tree are enlarged in TNC-null lungs throughout development (Figure 4). Proper lung development is highly sensitive to mechanical stimuli and pressure. Fetal breathing movements (34, 35) and spontaneous contractions of the future airways are important for proper lung development (23, 36). A compression of the lung, as occurred in oligohydraneous fetuses, impairs lung development (37). The expression of TNC at the terminal ends of the growing bronchial tree correlates with mechanical stimuli (15, 16, 32). Both fetal breathing movements (38) and spontaneous contractions of the future airways (23) are extending the terminal buds rhythmically. Our observed reduction of the number of branches in TNC-null lungs lets us speculate that TNC may be one of the factors transducing mechanical stimuli into cellular behavior. In summary, we were able to describe the first developmental phenotype of the TNC-null mouse that causes structural alterations of an organ. Most likely TNC contributes to lung branching morphogenesis by the control of cell migration during growth of the terminal endbuds and during cleft formation. Furthermore, it may take part in the transduction of important mechanical stimuli acting on the termiends of the growing bronchial tree.
The authors thank Drs. Reinhard Fässler and Peter H. Burri for continuous support and helpful discussions, and Mrs. Marianne Hofstetter, Mrs. Catherine Allemann-Probst, and Mrs. Bettina de Breuyn for expert technical assistance. This work was supported by grants of the Swiss National Science Foundation (no. 3100.55895.98 to Peter H. Burri and no. 3100.068256.02 to J.S.), of the Max Planck Society (Reinhard Fässler), and of the Deutsche Forschungsgemeinschaft (Reinhard Fässler), and by the Fonds de perfectionnement du CHUV, Lausanne (M.R.-K.). Received in original form November 22, 2002 Received in final form July 18, 2003
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Top
Abstract
Lung Development
0.05; **P 
